Skip to content

Effects of Action Observation Training (AOT) in the Achievement of Urinary Continence in Men After Robot-assisted Laparoscopic Prostatectomy (RALP)

Effects of Action Observation Training (AOT) in the Achievement of Urinary Continence in Men After Robot-assisted Laparoscopic Prostatectomy (RALP)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05311267
Enrollment
92
Registered
2022-04-05
Start date
2020-10-01
Completion date
2022-11-15
Last updated
2022-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Keywords

Robot-assisted Laparoscopic Prostatectomy, Action Observation Training, pelvic floor muscle training

Brief summary

Urinary incontinence (UI) is one of the most common side effects of radical prostatectomy (RP) and compromises men's quality of life. The first line treatment for urinary incontinence is the conservative approach of Pelvic Floor Muscle Training (PFMT) but, up to date, there seems to be no statistically significant difference in the effectiveness of several proposed physiotherapy treatments. Literature highlights the importance of also adding an educational component regarding the intentional contraction of the pelvic floor muscles (a skill termed the Knack). Moreover, in some studies, carried out on a sample of women, was introduced the use of virtual reality. This increased the adherence to treatment and showed an improvement in urinary continence. In addition to virtual reality, another intervention methodology used in physiotherapy is the one of Action Observation training (AOT) whose effectiveness has been proven both in sports and rehabilitation. However, currently the effect of this innovative type of treatment has not yet been studied in men with UI following radical prostatectomy intervention. The aim of this clinical study is to investigate the effectiveness of using AOT on urinary incontinence in subjects undergoing robotic radical prostatectomy.

Interventions

Subject is asked to observe videos with motor contents

Sponsors

Istituto Clinico Humanitas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Patients who have undergone Robot-assisted Laparoscopic Prostatectomy with post-operative IU. * Objectivity of recruitment and contraction of pelvic floor musculature (PP) at manual perineal testing.

Exclusion criteria

* Preoperative incontinence * Pre-intervention radiotherapy * Previous urogenital surgery beyond Robot-assisted Laparoscopic Prostatectomy. * Concomitant presence of neurological, internal or musculoskeletal diseases that may affect functional or motor recovery. * Less than 5 seconds of endurance in PP contraction

Design outcomes

Primary

MeasureTime frameDescription
Changes in continence using 24 hours pad testBoth groups will be evaluated 45 days after surgery (T0), 1-week after T0 (T1), 2 weeks after T0 (T2), 4 weeks after T0 (T4), 6 weeks after T0 (T6) and 8 weeks after T0 (T8), 3 months after T8 (T9).The primary outcome is to investigate if there is a difference in continence between the experimental and the control group at each physiotherapy session and compared to the baseline (T0).To quantify the extent of these losses, the weight of absorbent devices used by patients in the 24 hours prior to each evaluation will be measured.

Secondary

MeasureTime frameDescription
Changes in urinary symptoms using International Prostatic Symptoms Score (IPSS)Both groups will be evaluated 45 days after surgery (T0), 8 weeks after T0 (T8) or earlier in case of achievement of the primary goal in previous sessions (T1, T2, T4, T6), and 3 months after T8 (T9).The secondary objective is to investigate urinary symptoms using International Prostatic Symptoms Score (IPSS)
Changes in the quality of life using quality life index (QoL index) 0-6Both groups will be evaluated 45 days after surgery (T0), 8 weeks after T0 (T8) or earlier in case of achievement of the primary goal in previous sessions (T1, T2, T4, T6), and 3 months after T8 (T9).The secondary objective is to investigate the quality of life using quality life index 0-6
Changes in urinary symptoms using International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)Both groups will be evaluated 45 days after surgery (T0), 8 weeks after T0 (T8) or earlier in case of achievement of the primary goal in previous sessions (T1, T2, T4, T6), and 3 months after T8 (T9).The secondary objective is to investigate urinary symptoms using International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)

Countries

Italy

Contacts

Primary ContactRoberto MSc Gatti
Roberto.gatti@hunimed.eu0282245610

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026